Research study Program year 2025 Source: CMS Open Payments

A Phase 1 Study of ASP3082 in Participants With Previously Treated Locally Advanced or Metastatic Solid Tumor Malignancies With KRAS G12D Mutation

Research payments

$20,777,792

8,093 payments

Through program year 2025, $20,777,792 in research payments was reported against A Phase 1 Study of ASP3082 in Participants With Previously Treated Locally Advanced or Metastatic Solid Tumor Malignancies With KRAS G12D Mutation, across 8,093 payments, paid by Astellas Pharma Inc.

Paid by: Astellas Pharma Inc
ClinicalTrials.gov: No trial number was reported for this study

By program year

4 rows

Year	Kind	Amount	Payments
2025	Research	$10,881,340	3,580
2024	Research	$6,217,258	2,496
2023	Research	$3,055,119	1,856
2022	Research	$624,074	161

Breakdown

Who paid Research payments · program years 2022–2025

Astellas Pharma Inc $20,777,792 8,093 payments

Who received the money Research payments · program years 2022–2025

Memorial Sloan Kettering Cancer Center Organisation paid for research $3,014,337 999 payments
University Of Kansas Medical Center Research Institute INC Organisation paid for research $2,519,718 877 payments
Sarah Cannon Research Institute LLC Organisation paid for research $2,205,777 929 payments
Trustees of Columbia University Organisation paid for research $1,588,800 977 payments
Yale University Organisation paid for research $1,560,073 439 payments
Health Research INC Organisation paid for research $1,495,573 481 payments
Regents Of The University Of California Organisation paid for research $1,384,436 477 payments
Next Virginia LLC Organisation paid for research $1,331,428 770 payments
Vanderbilt University Medical Center Teaching hospital · TN $1,110,554 359 payments
Washington University Organisation paid for research $1,083,535 405 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

8 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.